The standard oral dose of tranexamic acid for heavy menstrual bleeding is about 3.9 to 4 grams per day, split into three doses of 1.3 grams each, taken for up to five days starting on the first day of your period.1PubMed Central. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety That regimen can cut menstrual blood loss roughly in half, and how you time the doses matters almost as much as how much you take. The details around dosing, duration, comparisons to other options, and safety caveats are worth understanding before you fill the prescription.
What the Drug Actually Does
Tranexamic acid is not a hormone. It works by slowing down the body’s clot-dissolving machinery. Normally, an enzyme system breaks down fibrin, the protein mesh that holds blood clots together. In the uterus during a heavy period, that clot-dissolving activity is ramped up, which keeps bleeding going longer and heavier than it should. Tranexamic acid blocks specific binding sites on the protein that drives clot breakdown, letting clots in the uterine lining stay intact longer and reducing overall blood loss.2PubMed. Tranexamic acid: a review of its use in the management of menorrhagia The drug has been used for heavy periods for over four decades, first coming out of a Japanese lab in the early 1960s.3PubMed. Tranexamic acid–an old drug still going strong and making a revival Because it targets the clotting system rather than your hormones, it does not change your cycle length, suppress ovulation, or affect fertility.
How to Take It and When to Start
The most widely studied and recommended regimen is 1,300 mg (two 650 mg tablets) taken three times a day, for a maximum of five days per cycle. You start on the first day of your period, not before it, and stop once bleeding tapers off or after five days, whichever comes first.4PubMed Central. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety Some earlier protocols used 1 gram every six hours for the first three days of the period rather than five, which is a slightly different split of a similar daily total.5Journal SOGC. Treatment of Menorrhagia with Tranexamic Acid The five-day, three-times-daily schedule is the one that appears in most current prescribing guidelines.
One practical point people often miss: this is an on-demand medication. You only take it during the days you are actually bleeding heavily. There is no daily pill to remember for weeks at a stretch, and you do not take it during the rest of your cycle. That intermittent schedule means your total drug exposure each month is relatively brief, which plays into the side-effect profile discussed below. If you forget a dose, take it when you remember and then resume the regular spacing. Do not double up to catch up.
Only about a third of each oral dose reaches your bloodstream. The rest passes through without being absorbed.6PubMed. Pharmacokinetics and bioavailability of tranexamic acid That low bioavailability is the reason the daily dose sounds high at nearly 4 grams. Your body clears what it does absorb primarily through the kidneys, which becomes relevant if you have any kidney issues.
How Much It Reduces Bleeding
Across studies, tranexamic acid cuts menstrual blood loss by somewhere between 26% and 60%, depending on the trial and the individual.7PubMed Central. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety One well-known head-to-head trial measured the reduction more precisely: women taking tranexamic acid saw a 54% drop in blood loss compared to their pre-treatment cycles, while those on mefenamic acid (an NSAID) saw only a 20% drop.8BMJ. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid In that study, average blood loss fell from around 143–178 ml during untreated cycles to roughly 72–75 ml on tranexamic acid.
Those numbers are group averages. Some women see dramatic improvement while others notice a more modest change. A randomized controlled trial found that compared to placebo, women on tranexamic acid reported significant improvements in how much bleeding interfered with social activities, physical activities, and work.9Obstetrics & Gynecology. Tranexamic Acid Treatment for Heavy Menstrual Bleeding: A Randomized Controlled Trial Perceived blood loss dropped enough that women could feel the difference in their daily lives, not just on a lab measurement.
How It Stacks Up Against Other Treatments
If you are weighing tranexamic acid against other options for heavy periods, the head-to-head data are reasonably clear on a few comparisons. A Cochrane review confirmed that NSAIDs as a class reduce heavy bleeding compared to placebo but are less effective than tranexamic acid.10PubMed Central. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding A clinical consensus statement from NASPAG also concluded that tranexamic acid outperforms scheduled NSAIDs and oral progestin therapy for reducing menstrual blood loss.11Journal of Pediatric and Adolescent Gynecology. NASPAG Clinical Consensus: Use of Tranexamic Acid in the Treatment of Heavy Menstrual Bleeding
Against combined oral contraceptives, the picture is closer. A study comparing the two directly found they were equally effective at reducing blood loss, with no statistically significant difference between groups.12PubMed Central. Efficacy of Oral Tranexamic Acid Versus Combined Oral Contraceptives for Heavy Menstrual Bleeding The practical difference is that the pill also provides contraception and may shorten your period, while tranexamic acid does neither. The pill, on the other hand, is a daily commitment all month long and carries its own hormonal side effects.
The treatment that consistently beats tranexamic acid is the levonorgestrel-releasing intrauterine system, commonly known by brand names like Mirena. One trial found the hormonal IUD reduced blood loss by about 82% after three months and nearly 96% after a year, compared to roughly 44% for tranexamic acid.13American Journal of Obstetrics and Gynecology. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia The IUD is a set-and-forget option lasting years, but it requires insertion, involves a hormonal component, and is not right for everyone. Tranexamic acid fills an important niche for people who want a non-hormonal option they can control cycle by cycle.
Common Side Effects
Most side effects are mild and temporary. In a long-term study following over 700 women through up to 27 treatment cycles, the most frequently reported issues were headache, menstrual discomfort, and back pain.14Women’s Health. Long-Term Evaluation of Safety and Health-Related Quality of Life in Women with Heavy Menstrual Bleeding Treated with Oral Tranexamic Acid Most of these were considered unrelated to the drug itself, and the majority were rated as mild to moderate. Nausea and gastrointestinal discomfort can happen, especially early on. Taking the tablets with food usually helps.
Overall tolerability is high enough that a significant number of women stay on the drug for many consecutive cycles. In that same long-term study, quality-of-life improvements appeared during the first treatment cycle and were maintained throughout the entire evaluation period.15Women’s Health. Long-Term Evaluation of Safety and Health-Related Quality of Life in Women with Heavy Menstrual Bleeding Treated with Oral Tranexamic Acid Patient satisfaction with tranexamic acid tends to run around 63%, which is comparable to satisfaction rates for norethisterone and somewhat lower than for the hormonal IUD.16Gynecologic and Obstetric Investigation. Comparison of Therapeutic Efficacies of Norethisterone, Tranexamic Acid and Levonorgestrel-Releasing Intrauterine System for the Treatment of Heavy Menstrual Bleeding: A Randomized Controlled Study When stacked against medroxyprogesterone acetate, tranexamic acid users reported fewer drug complications and higher satisfaction.17PubMed. Treatment of heavy menstrual bleeding of endometrial origin: randomized controlled trial of medroxyprogesterone acetate and tranexamic acid
Blood Clot Risk in Context
Because tranexamic acid works by stabilizing clots, the natural worry is whether it creates dangerous clots in the wrong places. This is the concern that gets the most attention, and it deserves a careful look. A large observational study found that the rate of venous blood clots in people using oral tranexamic acid was about 11.8 per 10,000 person-years, compared to 2.5 per 10,000 person-years in non-users, giving an adjusted rate ratio of roughly 4.18EClinicalMedicine. Oral tranexamic acid and risk of venous thromboembolism and arterial thrombosis That sounds alarming as a relative increase, but the absolute numbers are small: roughly 12 events per 10,000 person-years of use. For arterial clots like strokes or heart attacks, the same study found no statistically significant increase.
Several things are worth keeping in mind here. The study population included all users of oral tranexamic acid, not just those taking it for heavy periods a few days a month. People using it for other reasons may take it more frequently or have other risk factors. Older clinical trial data in the menstrual-bleeding population specifically have not found a clear increase in clotting events.19PubMed Central. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety Still, if you have a personal or strong family history of blood clots, deep vein thrombosis, or pulmonary embolism, your doctor will want to weigh that risk carefully before prescribing tranexamic acid. The same goes if you are also taking combined hormonal contraceptives, since both can influence clotting pathways.
Iron Levels and Anemia Recovery
Heavy periods are one of the most common causes of iron deficiency in premenopausal women. Reducing menstrual blood loss does not just mean fewer pad changes; it can reverse the slow drain on your iron stores that leaves you tired, foggy, and short of breath. A study tracking hemoglobin and ferritin levels found that among women who started with low hemoglobin, about a third had returned to the normal range after three treatment cycles, and nearly half had normalized after 27 cycles. For women who started with depleted ferritin, about 35% had recovered after six cycles and 58% after 27 cycles.20PubMed. Tranexamic acid increases hemoglobin and ferritin levels in women with heavy menstrual bleeding
A smaller clinical trial recorded a similar pattern: hemoglobin rose from an average of about 11.9 to 13.1 g/dl over the treatment period, and ferritin levels climbed as well. Quality of life improved across nearly every dimension measured.21Journal of Arak University Medical Sciences. The effect of tranexamic acid on the quality of life and blood loss of women with menorrhagia: A clinical trial The recovery is gradual rather than instant, because your body needs months of reduced losses before its iron reserves rebuild. Some clinicians recommend supplementing iron alongside tranexamic acid to speed that process, though the drug trials themselves did not always require it.
Dosing for Adolescents
Heavy periods often begin in the first few years after menarche, and the options for teenagers can feel limited. Many adolescents and their parents prefer to avoid hormonal contraceptives, which makes tranexamic acid appealing. The dose studied in adolescents is the same as in adults: 1,300 mg three times daily for the first five days of the period. An open-label study in patients 18 and under found that this regimen led to clinically meaningful reductions in blood loss and was well tolerated, with no serious medication-related adverse events.22PubMed. An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents with Heavy Menstrual Bleeding
A pilot study comparing tranexamic acid to combined oral contraceptives in adolescents found that both reduced blood loss and improved quality of life by similar amounts, with no statistically significant difference between the two. The contraceptive pill group did see a reduction in the length of their period, which tranexamic acid did not achieve. Adverse events were more common in the pill group.23PubMed. Oral Tranexamic Acid versus Combined Oral Contraceptives for Adolescent Heavy Menstrual Bleeding: A Pilot Study For teens with heavy bleeding who do not need contraception or prefer a non-hormonal option, tranexamic acid is a reasonable first-line choice.
When Kidney Function Matters
Tranexamic acid is cleared almost entirely through the kidneys. If your kidneys are not working at full capacity, the drug builds up in your system, which raises the risk of side effects and toxicity.24PubMed. Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases Pharmacokinetic modeling has shown that patients with chronic kidney disease who receive the standard dose end up with plasma concentrations significantly higher than intended.25Biopharmaceutics & Drug Disposition. Pharmacokinetic modeling of tranexamic acid for patients undergoing cardiac surgery with normal renal function and model simulations for patients with renal impairment If you have known kidney problems, your doctor will reduce the dose or adjust the dosing interval to keep blood levels in the safe range. This is not a situation to self-manage; the adjustments depend on how impaired your kidney function actually is.
Rare Visual Side Effects
One of the stranger and less well-known potential side effects involves changes in color vision. Case reports describe patients who developed altered color perception shortly after starting oral tranexamic acid. In one case involving a patient taking it for nosebleed prevention, color vision disturbances appeared soon after initiation and resolved once the drug was stopped.26PubMed Central. Color vision disturbances secondary to oral tranexamic acid A separate report described transient visual loss after a single intravenous dose during surgery, which resolved over two days without lasting damage.27Anaesthesia Reports. Postoperative bilateral visual loss after a single dose of tranexamic acid These events are rare enough that most prescribing clinicians have never encountered one, but they are worth being aware of. If you notice any change in your vision while taking tranexamic acid, stop the drug and contact your doctor promptly. The long-term safety study that tracked over 700 women included regular ophthalmologic examinations and did not flag a pattern of visual problems at the standard dose for heavy bleeding.28Women’s Health. Long-Term Evaluation of Safety and Health-Related Quality of Life in Women with Heavy Menstrual Bleeding Treated with Oral Tranexamic Acid
Origins and Expanding Uses
Tranexamic acid has an unusual backstory for a drug that many people have never heard of. It was developed in the early 1960s by Shosuke and Utako Okamoto, and heavy menstrual bleeding was one of the very first conditions it was used for.29International Journal of Epidemiology. Tranexamic acid—a recipe for saving lives in traumatic bleeding From there, its use expanded to hereditary bleeding disorders and then to elective surgery, where it reduces the need for blood transfusions by roughly a third.30International Journal of Epidemiology. Tranexamic acid—a recipe for saving lives in traumatic bleeding It has since become a cornerstone of trauma medicine and is on the World Health Organization’s List of Essential Medicines. Despite that pedigree, it remained relatively obscure for menstrual bleeding in some countries for decades, partly because it was available generically in many places but lacked a branded formulation marketed specifically for periods until more recently. In the United States, the branded version Lysteda was approved for heavy menstrual bleeding in 2009, which brought it more attention from both clinicians and patients in that market. The drug itself was not new; the awareness was.